PATH vs VMD
Uipath Inc (PATH) versus Viemed Healthcare Inc (VMD) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Viemed Healthcare Inc (VMD) is a medical devices company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported VMD revenue for 2024-12-31 was $224.3M. Net income was $11.4M. Revenue was up 22.5% from 2023-12-31 to 2024-12-31. VMD currently screens at market cap $403.7M and trailing P/E 28.5.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. VMD currently screens at market cap $403.7M and trailing P/E 28.5.
Not investment advice. Open the PATH and VMD stock pages for the full models.
Not investment advice.